​

Funding Round

Post-IPO Debt - Lucira Health

Post-IPO Debt - Lucira Health

Investment Firm

Overview

Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.

Announced Date

Feb 04, 2022

Funding Type

Post Ipo Debt

Highlights

Location

United States, North America

Social

Investor Lead

Silicon Valley Bank

Silicon Valley Bank

Silicon Valley Bank is a debt and early_stage_venture and late_stage_venture and private_equity firm.

Hercules Capital

Hercules Capital

Hercules Capital is a debt and late_stage_venture and post_ipo and venture firm.

Participant Investors

3

Investor Name
Participant InvestorArmentum Partners
Participant InvestorHercules Capital
Participant InvestorSilicon Valley Bank

Round Details and Background

Lucira Health raised $80000000 on 2022-02-04 in Post-IPO Debt

Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 01, 2018
Convertible Note - Lucira Health
1-undefined
Aug 05, 2019
Series B - Lucira Health
2-15.0M
Oct 09, 2015
Series A - Lucira Health
7-13.1M
Dec 01, 2014
Seed Round - Lucira Health
4-2.0M

Recent Activity

There is no recent news or activity for this profile.